The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms.
F.D.A. to Relabel Leucovorin for Autism Treatment

The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms.